Update: BofA Downgrades Addus HomeCare to Neural From Buy, Adjusts PT to $125 From $140
(Updated to include prior price target in headline.)Addus HomeCare (ADUS) has an average rating of overweight and mean price target of $133.69, according to analysts polled by FactSet.